BIOINVEST BREAKING NEWS – Skye (SKYE) – SKYE has announced a complete pivot away from Nimacimab and is merging with private U.K company Redx Pharma. The combined company will be named Fibrex Therapeutics and will focus on developing Redx’s fibrosis portfolio. (…more)
To access this post, you must have an active subscription to the Medical Technology Stock Letter. Please login if you are a current subscriber. Thank you.